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Abstract
Background: Adherence to treatment in children with juvenile idiopathic arthritis (JIA) is associated with better
outcomes. Assessing patient adherence in JIA, as well as attitudes and beliefs about prescribed treatments, is
important for the clinician in order to optimize patient management. The objective of the current study was to
evaluate the psychometric properties of the Parent (proxy-report) Adherence Report Questionnaires (PARQ), which
assesses beliefs and behaviors related to adherence to treatments prescribed for JIA.
Methods: A Rasch analysis was conducted on data collected with parents of children with JIA from two studies in
which the PARQ was used as a measure of adherence.
Results: The PARQ showed preliminary evidence of multidimensionality with two factors, accounting for 38 % and
27 % of the variance respectively. The PARQ in its original version does not adhere to expectations of the Rasch
model. A transformed version of the PARQ obtained by deletion of the general adherence scale and modification
of visual analog scales into 5-point likert scales improved fit to the model and showed preliminary evidence of
unidimensionality.
Conclusions: The PARQ was transformed based on the results of the Rasch analysis. The transformed version of the
PARQ shows preliminary evidence of unidimensionality and may allow computation of a total score, although
further testing is needed to verify these findings.
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Background
Higher levels of adherence are associated with better
health outcomes among children with chronic diseases
[1] including juvenile idiopathic arthritis (JIA) [2, 3].
Valid, reliable, and easy to administer measures assessing
patient adherence, as well as factors associated with ad-
herence to prescribed treatments, must be available for
use in clinical practice in order to optimize patient man-
agement [1]. In JIA, adherence may involve gaining ac-
cess to the medications, taking the right dosage at the
appropriate times, as well as performing prescribed exer-
cises and wearing splints according to the instructions of
their therapist. Although there is no gold standard to
assess adherence [1], using patient self-report question-
naires is the most common and practical way to evaluate
adherence [1]. A few questionnaires have been devel-
oped to assess adherence in pediatric chronic diseases
such as JIA but none assesses adherence to the various
modalities used in JIA in a valid manner [1].
Our research team developed the Parent Adherence
Report Questionnaire (PARQ) aimed at measuring pa-
tient and parent beliefs and behaviors related to adher-
ence to various treatments prescribed for JIA in order to
elucidate adherence issues and act upon them [4, 5]. The
PARQ has shown satisfactory construct validity and test-
retest reliability using Classical Test Theory [4]. How-
ever, the assumption of unidimensionality, imperative
for construct validation and proof of interval-level meas-
urement permitting the summation of individual items
into a total score, have not been verified. Also, other
* Correspondence: ktoupin@cheo.on.ca
1Children’s Hospital of Eastern Ontario Research Institute, 401 Smyth Road,
room R1132, Ottawa, Ontario, Canada
2Department of Pediatrics, University of Ottawa, Ontario, Canada
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Toupin April et al. Pediatric Rheumatology  (2016) 14:45 
DOI 10.1186/s12969-016-0105-5
important psychometric properties such as the useful-
ness of the response categories for each item and
differential item function (item bias) have not been in-
vestigated. At this time, the interpretation of the PARQ
remains mostly qualitative, as no overall score can be
derived from the individual items. Rasch analysis, a
modern model for evaluating psychometric properties of
self-report measures, can provide this valuable informa-
tion and informs on how well the items contribute to
defining the construct of the questionnaire: adherence to
treatment in children [6]. The aim of the present study
is to evaluate the PARQ using Rasch analysis.
Methods
Instruments
The development of the PARQ was guided by the World
Health Organization (WHO) conceptual framework [7],
as well as a literature review of studies on adherence in
general pediatrics and JIA [4]. The WHO model is com-
prised of five dimensions of factors associated with ad-
herence: 1) social and economic factors, 2) health care
team and system-related factors, 3) condition-related
factors, 4) therapy-related factors, and 5) patient-related
factors [7]. Several consultations with a team of pediatric
rheumatology health professionals were performed to
identify elements that should be included in the ques-
tionnaire [4]. Once the PARQ was developed, this team
was consulted to determine its face and content validity,
and its feasibility [4].
The PARQ was tested for construct validity and test-
retest reliability, which were shown to be satisfactory
when medication and exercise scores were compared
with the General Adherence Scale and to diary reports
of medication and exercise-related behaviors [4]. The
PARQ was pilot tested for ease of use in five English-
speaking caregivers of youth with JIA, and translated
into French by a bilingual professional translator [4].
The PARQ has since been used in various research
projects [3, 5, 8] and a child-report version (i.e., Child
Adherence Report Questionnaire (CARQ)) has been de-
veloped and pilot-tested among youth with JIA [3, 5].
The PARQ focuses on the domain of patient-related
factors (e.g., knowledge, attitudes, beliefs, perceptions,
and expectations) of the WHO model. It assesses which
member of the family is responsible for making sure that
the child adheres to treatment. The following items are
scored on a 100 mm visual analog scale (VAS):
frequency with which children follow their prescribed
treatments (medication, exercise regimen and splints),
difficulties experienced in following the various forms of
treatment, the frequency of negative reactions associated
with following the various forms of treatment, and the
degree to which the treatments are perceived as helpful.
The Morisky scale, an index addressing barriers to
medication adherence [9] is also included in the PARQ.
The Morisky scale is comprised of four yes/no questions
related to forgetting to take medication, neglecting to
take medication, stopping the medication when the child
felt better or worse than before, and choosing a type of
medication (4-point scale). Finally, parent and child
treatment preferences and perceptions regarding treat-
ment helpfulness and also dissatisfaction with care are
included as these may influence adherence.
Procedure
Rasch analyses were performed on data collected from
two studies conducted in Vancouver and Montreal
(Canada) in which the PARQ was used as a measure of
adherence. The first study was a longitudinal survey
assessing the adherence to treatment and its associated
factors (e.g., child’s disease severity, child’s age, care-
givers’ perceived helpfulness of treatments, use of com-
plementary and alternative health care) in a sample of
parents of 180 children with JIA [2, 8]. The second was
a cross-sectional survey of 55 children with JIA and their
parents to compare their respective perceptions of treat-
ment adherence and quality of life and to determine the
association between adherence and health outcomes [5].
In both studies, we also assessed health related quality of
life (HRQOL) using the Juvenile Arthritis Quality of Life
Questionnaire (JAQQ) and extracted information from
medical charts on disease severity (using the active joint
count, representing the number of joints with active in-
flammation as rated by the rheumatologist) and disease
duration. Thus, from the two studies, we had a total of
235 PARQ baseline questionnaires for this study.
Analysis
First, a principal component analysis (PCA) was per-
formed to determine the factor structure and the dimen-
sionality of the PARQ questionnaire using SAS (version
9.0). Rasch analyses were then conducted to assess how
well the data fit the Rasch partial credit model. Content
validity, construct validity, as well as other psychometric
properties, such as the appropriateness of response cat-
egories, floor and ceiling effects, item bias and reliability
were evaluated. The RUMM 2030 [10] computer soft-
ware program was used for Rasch analyses [11].
Principal component analysis
We analyzed the PARQ baseline data to perform a pre-
liminary examination of its dimensionality and factor
structure using PCA [12].
Rasch analyses
Baseline data were analyzed to evaluate their fit to the
Rasch partial credit model [13]. This model is used when
items within a test or index are scored on different
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scales. Indeed, the PARQ items are scored on a dichot-
omous scale (0–1), an ordinal scale (0 to 4) and a VAS
(0 to 100 mm). The Rasch model describes the relation-
ship between an item and a person’s response to this
item and is useful in validating measures. When items
meet the expectations of the Rasch model, they are said
to ‘fit’ the model and they are placed in order of diffi-
culty along a ruler or scale that represents the trait
under study, which is adherence in this case. On this
‘item-person map’, the bars represent the distribution of
items according to their difficulty and the distribution of
persons according to their ability to adhere to treatment.
Easy items are located towards the left of the graph
while difficult items are at the right. Likewise, persons
who exhibit lower adherence to treatment are located
towards the left and those exhibiting higher levels of ad-
herence are located towards the right (see Fig. 1). In the
case of the PARQ questionnaire, difficult items are items
for which achieving adherence is harder to attain and
the ability of a person represents their level of adherence
to a particular treatment.
Ideally, for items to “fit” the model and for the ques-
tionnaire to have adequate content validity, items should
be spread evenly on the continuum of difficulty level
and have a wide range (from at least −3 to +3 logits)
(see Fig. 1).
Construct validity is attained when persons and items
have adequate fit statistics (e.g., item and person stan-
dardized fit residuals between ±2.5 with a mean of 0 and
non-significant chi-squares and F statistics). These
methods and their criteria are fully described elsewhere
[14–17]. Construct validity is also attained when none of
the items display differential item functioning (DIF) or
item bias [18]. Items are considered biased if they
change their level of difficulty depending on the group
of persons being assessed (e.g., boy vs. girl), which vio-
lates the expectations of the Rasch model. DIF was
deemed to be present if analyses of variance were signifi-
cant (Bonferroni-corrected p value of 0.001389).
The usefulness of the response categories was assessed
for adequacy of their response options. For polytomous
items, responses should be adequately distributed across
the response categories, and this is usually indicated as a
minimum of 10 observations in each rating scale cat-
egory [19]. The reliability of the questionnaire was
assessed by the person separation index, which is inter-
preted as a Cronbach’s α [20]. It indicates how well the
items discriminate persons into different ability levels.
Results
Participants’ characteristics
Characteristics of the participants included in the
analyses are shown in Table 1. The distribution of JIA
was as follows: polyarthritis (23.61 %), oligoarthritis
(36.48 %), enthesitis-related arthritis (11.16 %), systemic
arthritis (9.44 %), psoriatic arthritis (10.30 %) or another
type of arthritis (9.01 %). In terms of treatments, 76.09 %
of children were prescribed medication (mostly NSAIDs
(54.89 %), non-biologic DMARDs (45.53 %) or TNF
alpha inhibitors (6.38 %), corticosteroids (8.94 %)),
68.85 % were given exercises and 15.43 % were pre-
scribed splints. Mean scores on 100 mm VAS for the
parent-reported adherence to medication, exercises
and splints were 86.14 mm (SD = 25.98 mm), 54.52 mm
Fig. 1 Person-item threshold distribution. Figure 1 shows the distributions of persons (top) and items (bottom) for the transformed PARQ. The
item thresholds spread from approximately −10 to 13 logits, which is adequate
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(SD = 31.65 mm) and 49.18 mm (SD = 41.21 mm) respect-
ively. Mean scores for the parent-reported difficulty in fol-
lowing medication, exercises and splints were 20.51 mm
(SD = 25.93 mm), 35.99 mm (SD = 30.11 mm) and
34.89 mm (SD = 37.29 mm) respectively. Medication was
felt to be the most helpful (mean score = 83.30 mm,
SD = 24.74 mm) compared to exercises (mean score =
67.64 mm, SD = 29.95 mm) and splints (mean score =
65.07 mm, SD = 35.56 mm).
Principal component analyses
While the type of data for some of the items (ordinal)
along with missing data precluded definite conclusions
about the factor structure revealed by the PCA, it helped
us identify and understand the number of dimensions
within the construct and to identify items unrelated to a
one-dimensional concept of adherence. The PCA indi-
cated the presence of two main factors that explained 38
and 27 % of the variance respectively. Most of the 17 items
loaded on the first factor. However, three items did not
load on the first factor: Forgetting to take medication dur-
ing the last 3 months, neglecting to take medication dur-
ing the last 3 months and difficulty in doing prescribed
exercises. These items appear to form a second factor and
may contribute to the multi-dimensionality of the scale.
All items were retained for the Rasch analyses of the
PARQ questionnaire.
Rasch analyses
The fit of the baseline data when all 17 items of the
PARQ were considered produced a significant item-trait
interaction (chi-square = 244.76; p < 0.05). This is an in-
dication that the data did not fit the Rasch model. All
items originally scored as a visual analog scale displayed
disordered thresholds meaning that the scoring op-
tions (0–100 mm) were not adequate. Most response
options were massively underutilized. The fit of the
individual items revealed that 5 out of 17 items did
not fit the model.
In order to determine whether transforming the PARQ
by re-categorizing of the scoring options would improve
item fit and overall fit, items were re-scored. When five
(0–4) scoring options were created for the items scored
on a VAS, all thresholds were ordered. Response options
0 and 100 mm were kept and became 0 and 4. Response
options from 1 to 29 mm became a 1 while response op-
tions 30–89 mm were scored a 2. Finally, response op-
tions 90–99 mm were scored as a 3. This rescoring
structure offered the best fit for all VAS items. Once re-
scoring was completed, all VAS items fit the model but
the five remaining items of the Morisky scale did not
(Table 2). The removal of these five items resulted in the
VAS items all fitting the model. The data fitted the
model with an overall non-significant chi-square (95.26
p = 0.80).
As for content validity, it was assessed by examination
of the item-person map (Fig. 1), which shows the distri-
butions of persons (top) and items (bottom) for the
transformed PARQ. The item thresholds spread from
approximately −10 to 13 logits, which is adequate.
Evidence of construct validity was ascertained as all
items and persons had adequate fit statistics and none
displayed DIF. The usefulness of the response categories
was ascertained as all were found to have adequate fit
statistics. Responses were also adequately distributed
across the response categories, as there were more than
10 observations in each rating scale category.
Figure 1 is also useful for evaluating ceiling and floor
effects. As no persons are located to the right or the left
of the outermost items at the right and left of the graph,
no ceiling or floor effects are present. The reliability
index was 0.69 indicating that the transformed PARQ
can reasonably discriminate persons into different
ability levels. The new version of the PARQ is shown in the
Appendix (https://www.dropbox.com/sh/tcdckuc6kfyd0vn/
AAAu3yYHbD2uWOgCg9Lu3N3ha?dl=0).
To assess whether the transformed PARQ is unidi-
mensional, we performed a post-hoc test of unidimen-
sionality. According to the Smith’s t-tests [21], 6 out of
211 t-tests (2.84 %) showed significant differences in the
estimates generated. Because less than 10 % of the t tests
are significant, the transformed PARQ is considered uni-
dimensional [22].
Discussion
The aim of the present study was to evaluate the psy-
chometric properties of the PARQ. Results of the PCA
showed preliminary evidence of the multidimensionality
of the original version of the PARQ and did not meet
the expectations of the Rasch model. The questionnaire
was transformed to determine if we could achieve a
Table 1 Demographic and disease related characteristics of the
families included in the analyses for the PARQ
Characteristics PARQ data
n = 235 parents of children with JIAa
Children’s sex, female, n (%) 169 (71.91)
Children’s age, years, mean (SD) 10.80 (4.19)
Disease duration, years, mean (SD) 4.66 (3.79)
Disease severity, AJC, mean (SD) 1.62 (3.37)
HRQOL, mean (SD)b 2.20 (1.12)
Pain, mean (SD)c 17.18 (22.81)
SD standard deviation, AJC active joint count
aThe sample size includes families involved in the two studies: families of 180
children and 55 children
bOn a scale from 1 to 7, 7 being a worse HRQOL
cOn a visual analog scale from 0 to 100, 100 being worse pain
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better fit to the Rasch model. These transformations in-
clude modifying the scales of some of the items (from
VAS to five point Likert scale) and removing the
Morisky scale items. After transformation, the items met
the expectations of the Rasch model. This means that
the PARQ assesses parent beliefs and behaviors related
to adherence to various treatments prescribed for JIA in
a cohesive manner (i.e., unidimensional). This will also
allow for the computation of a total score, thus facilitat-
ing the use of the questionnaire and the conduct of
quantitative analysis. Such a score is important to en-
sure the interpretability of the measure [23] and to
facilitate communication amongst researchers and
health professionals.
To our knowledge, the PARQ is the first proxy-report
questionnaire assessing adherence to various JIA treat-
ments which has undergone validity testing using Rasch
analysis. Furthermore, this questionnaire is the only one
to evaluate adherence to JIA treatments, as well as both
parents’ attitudes and beliefs about these treatments.
Assessing not only adherence behaviors but also related
beliefs is important to optimize adherence, as they are
the most important predictors of reported adherence [2].
The Rasch-validated version of the PARQ is a first step
towards establishing a total score indicator of adherence.
The transformed PARQ shows preliminary evidence of
unidimensionality and may allow computation of a total
score. Limitations of the current study include the type
of data for some of the items (ordinal) along with miss-
ing data, which precluded definite conclusions about the
factor structure revealed by the PCA. Although missing
data lowered the validity of the fit statistics in the Rasch
analysis, the estimates of the fit statistics should not be
biased [24] as the sample size was sufficient [25].
Further testing is needed to ensure the unidimension-
ality of the transformed version of the PARQ and to en-
sure its psychometric characteristics. Such endeavour is
underway in a different sample of parents of youth with
JIA. Using the PARQ will help to document parents’
beliefs and behaviors related to adherence to various
treatments prescribed for JIA, to identify adherence is-
sues and to put in place measures to ensure optimal ad-
herence and health outcomes. The PARQ can play an
important role in research to help assess whether adher-
ence is optimal in intervention studies in order to judge
the effectiveness of a treatment. This questionnaire can
also play an important role in clinical practice to help
start a discussion to better understand parents’ attitudes
and beliefs about JIA treatments in order to address bar-
riers to adherence.
Future studies will also aim at validating the child-
report version (CARQ), which would allow for assessing
children’s report of adherence to JIA treatments, as well
as their attitudes and beliefs about these treatments.
Assessing children’s and parents’ perceptions about
treatments is particularly important since they have been
shown to differ [5]. Using the PARQ and CARQ in com-
bination could help health professionals to thoroughly
assess family’s perceptions and behaviours about treat-
ments, communicate information about the various
treatments, and tailor treatments to both children’s and
parents’ needs.
Conclusions
The current research represents an important step in
evaluating the psychometric properties of the PARQ, a
questionnaire that assesses beliefs and behaviors related
to adherence to treatments prescribed for JIA. The
Table 2 The remaining PARQ items and their psychometric properties by location order once rescored and misfitting items
removed
Description/Item Location SE Fit residual
Difficulty in taking prescribed medication −1.11 0.15 −0.07
Negative reaction to taking prescribed medication −1.98 0.10 0.54
Negative reaction to doing prescribed exercises −1.96 0.12 0.38
Negative reaction to wearing splint −1.73 0.24 −0.11
Difficulty in exercises −1.72 0.13 0.56
Difficulty in wearing splint −1.21 0.23 1.50
Adherence to taking prescribed medication 0.57 0.14 −0.39
Usefulness of taking prescribed medication 0.71 0.14 0.13
Usefulness of doing prescribed exercises 1.94 0.13 0.72
Adherence to doing prescribed exercises 2.36 0.14 −0.75
Usefulness of wearing splint 2.40 0.25 −0.33
Adherence to wearing splint 2.74 0.22 0.41
All items had non-significant chi-squares and F statistics
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Rasch analysis led to the transformation of the PARQ
showing preliminary evidence of unidimensionality. Fu-
ture work will verify these findings and also validate a
child-report version of this questionnaire to thoroughly
assess treatment adherence and address its barriers, both
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